Skip to main content
Skip to Footer

American Journal of Psychiatry

  • Volume 172
  • Number 6
  • June 2015

Perspectives

Editorials

Perspectives

Introspection

Perspectives

Clinical Case Conference

Perspectives

Images in Psychiatry

Review and Overviews

Publication date: 01 June 2015

Pages519–530

Anxiety disorders are common in adolescents (ages 12 to 18) and contribute to a range of impairments. There has been speculation that adolescents with anxiety are at risk for being treatment nonresponders. In this review, the authors examine the efficacy ...

https://doi.org/10.1176/appi.ajp.2015.14081061

New Research

Articles

Publication date: 18 May 2015

Pages531–542

Objective: Heavy alcohol use during adolescence may alter the trajectory of normal brain development. The authors measured within-subject changes in regional brain morphometry over longer intervals and in larger samples of adolescents than previously ...

https://doi.org/10.1176/appi.ajp.2015.14101249

Publication date: 18 May 2015

Pages543–552

Objective: The genetic component of alcohol use disorder is substantial, but monozygotic twin discordance indicates a role for nonheritable differences that could be mediated by epigenetics. Despite growing evidence associating epigenetics and psychiatric ...

https://doi.org/10.1176/appi.ajp.2014.14030382

Publication date: 20 February 2015

Pages553–560

Objective: The authors sought to clarify the sources of parent-offspring resemblance for drug abuse, alcohol use disorders, and criminal behavior, using a novel genetic-epidemiological design. Method: Using national registries, the authors identified rates ...

https://doi.org/10.1176/appi.ajp.2014.14091127

Publication date: 13 February 2015

Pages561–569

Objective: The authors evaluated the potential of methylphenidate to improve antidepressant response to citalopram, as assessed by clinical and cognitive outcomes, in elderly depressed patients. Method: The authors conducted a 16-week randomized double-blind ...

https://doi.org/10.1176/appi.ajp.2014.14070889

Publication date: 10 April 2015

Pages579–585

Objective: Clozapine’s potent antagonism of muscarinic M1 receptors is thought to worsen working memory deficits associated with schizophrenia. In contrast, its major metabolite, N-desmethylclozapine (NDMC), is thought to enhance working memory via its M1 ...

https://doi.org/10.1176/appi.ajp.2015.14050673

Communications and Updates

Letters to the Editor

Communications and Updates

Book Forum

Communications and Updates

Books Received

Past Issues

View Issues Archive
No.11
View Issue
1 Nov 2024

Vol. 181 | No. 11

No.10
View Issue
1 Oct 2024

Vol. 181 | No. 10

No.9
View Issue
1 Sep 2024

Vol. 181 | No. 9

No.8
View Issue
1 Aug 2024

Vol. 181 | No. 8